Case Study: Global Biopharma Company achieves 50% faster, near‑perfect clinical labeling with Lionbridge

Overcoming Clinical Labeling Translation Challenges

Global Biopharma Company, a U.K.-headquartered global biopharma focused on infectious diseases and oncology, needed accurate, scalable translations for Investigational Medicinal Product (IMP) labels. Lionbridge has supported the customer since 2016 with clinical labeling translation services (delivered via Lionbridge Language Cloud™) and faced three core challenges: mixed right-to-left Hebrew and Latin text and “forbidden” characters that misrendered in the customer system, expansion and line‑break issues in Asian languages (Thai, Korean, Japanese), and tight regulatory timelines with roughly 18–20% rush orders.

Lionbridge delivered XML and Excel files with color‑coded placeholders for variables, inserted Unicode control characters and a script to replace problematic Hebrew characters, provided line‑break options for Asian translations, and integrated deliverables through Lionbridge Language Cloud. Those measures produced measurable impact: 99.3% of projects delivered on time, 50% faster turnaround than the initial agreement, 19.8% of projects delivered early, a 99.85% error‑free rate, and support across 36 target languages (678 phrases translated in 2022), enabling faster, more accurate clinical labeling for trials.